# nanosynth group enter funding arrangements with Lanstead

- Link: https://www.directorstalkinterviews.com/nanosynth-group-enter-funding-arrangements-with-lanstead/4121079385
- Published: 2022-08-26T07:04:39+01:00
- Author: Giles

**nanosynth Group plc** (LON:NNN), the AIM quoted company specialising in the synthesis
and application of nanoparticles to create new and improve existing products, has
announced a conditional subscription to raise £2,942,500 through the issue of 535,000,000
new ordinary shares of 0.01 pence each in the Company at a price of 0.55 pence per
Ordinary Share to institutional investor Lanstead Capital Investors L.P., together
with a related sharing agreement pursuant to which the Company pledges the gross
proceeds of the Lanstead Subscription.

**Highlights**

·    Subscription for 535,000,000 new Ordinary Shares by Lanstead at an Issue Price
of 0.55 pence to raise £2,942,500

·    The Issue Price of 0.55 pence represents a 20.9 per cent. premium to the closing
mid-market price (of 0.455 pence) of the Ordinary Shares on 25 August 2022, the 
latest business date prior to the announcement of the Subscription

·    The £2,942,500 gross proceeds of the Lanstead Subscription will be pledged 
to Lanstead by the Company pursuant to a Sharing Agreement with Lanstead. The Sharing
Agreement, details of which are set out below, entitles the Company to receive back
those proceeds on a _pro rata_ monthly basis over a period of 24 months, subject
to adjustment upwards or downwards each month depending on the Company’s share price
at the time relative to the Benchmark Price of 0.7333 pence per share. The monthly
settlement amounts for the Sharing Agreement are structured to commence approximately
one month (or earlier by agreement with Lanstead) following Admission

·    The Sharing Agreement provides the opportunity for the Company to benefit from
positive future share price performance; an underlying reason for undertaking the
fund raise in this way

·    The proceeds of the Sharing Agreement, will be used primarily to fund its working
capital requirements as the Company looks to commercialise its bespoke nanoparticle
technology

> **Mark Duffin, Chief Executive of nanosynth Group, commented:** “We are delighted
> to have entered into these funding arrangements with Lanstead at a particularly
> exciting time in the development of our business. The business is continuing to
> see significant levels of interest across the seven new verticals in which the
> Company is focusing its efforts and it will update the market on further developments
> in due course.”

**Introduction**

Lanstead has conditionally agreed to subscribe for the Lanstead Subscription Shares
at the issue price of 0.55 pence for gross proceeds of £2,942,500. The Subscription
proceeds will be pledged to Lanstead under the Sharing Agreement pursuant to which
the Company is entitled to receive back those proceeds on a pro rata monthly basis
over a period of 24 months, subject to adjustment upwards or downwards each month
depending on the Company’s share price at the time.

A significant factor in nanosynth’s decision to enter into the Subscription is that
the Sharing Agreement provides the opportunity for the Company to benefit from positive
future share price performance.  There is no upper limit placed on the additional
proceeds which could be received by the Company as part of the monthly settlements
and the amount available in subsequent months is not affected.  Whilst the Company
notes the corresponding risk that a fall in nanosynth’s share price could reduce
the amount of proceeds received, as explained below, the Directors expect the Company’s
strategy to make considerable positive advancements over the 24-month term of the
Sharing Agreement. If these advancements are successful, and if the success of these
advancements is reflected in nanosynth’s share price, the Company expects the proceeds
to be received from Lanstead to exceed the amount pledged under the Sharing Agreement.

**Further information on the Lanstead Subscription**

Pursuant to the subscription agreement between the Company and Lanstead (the **“**
Lanstead Subscription Agreement**“**), 535,000,000 new Ordinary Shares have today
been allotted and will be issued, conditional upon Admission, to Lanstead at 0.55
pence per Lanstead Subscription Share for an aggregate subscription value of £2,942,500.

The Lanstead Subscription proceeds of £2,942,500 will immediately following Admission
be pledged to Lanstead under the Sharing Agreement under which Lanstead will then
make, subject to the terms and conditions of that Sharing Agreement, monthly settlements(
subject to adjustment upwards or downwards) to the Company over 24 months, as detailed
below.  As a result of entering into the Sharing Agreement, the aggregate amount
received by the Company under the Lanstead Subscription and the Sharing Agreement
may be more or less than £2,942,500, as further explained below. **Notwithstanding
the Subscription Price of 0.55 pence, shareholders should note that the share price
of the Company needs to be on average over the 24 months of the Sharing Agreement
at or above the Benchmark Price of 0.7333 pence per share for the Company to receive
at least, or more than, the gross Subscription of £2,942,500.**

The Lanstead Subscription Shares will be issued credited as fully paid and will 
rank _pari passu_ in all respects with the Company’s existing issued Ordinary Shares.
The Lanstead Subscription is conditional, _inter alia_, on admission of the Lanstead
Subscription Shares to trading on AIM, and there being: (i) no breach of certain
customary warranties given by the Company to Lanstead at any time prior to Admission(
which is expected on or around 01 September 2022); and (ii) no force majeure event
occurring prior to Admission.  

**The Sharing Agreement**

In addition to the Lanstead Subscription, the Company has entered into the Sharing
Agreement, pursuant to which nanosynth will pledge the £2,942,500 gross proceeds
of the Lanstead Subscription to Lanstead.  The Sharing Agreement will enable the
Company to share in any share price appreciation over the Benchmark Price (as defined
below**).  However, if the Company’s 20 day Volume Weighted Average Share Price 
is less than the Benchmark Price then the amount received by the Company under the
Sharing Agreement will be less than the gross proceeds of the Lanstead Subscription
which were pledged by the Company to Lanstead at the outset.**

The Sharing Agreement provides that the Company will receive 24 monthly settlement
amounts as measured against a benchmark share price of 0.7333 pence per Ordinary
Share (the “Benchmark Price”). The monthly settlement amounts for the Sharing Agreement
are structured to commence approximately one month (or earlier by agreement with
Lanstead) following Admission.

If the measured share price (the”Measured Price”), calculated as the average of 
each day’s volume weighted share price (“VWAP”) of the Company’s Ordinary Shares
over a 20-day period prior to the monthly settlement date, exceeds the Benchmark
Price, the Company will receive more than 100 per cent. of that monthly settlement
due on a _pro rata_ basis according to the excess of the Measured Price over the
Benchmark Price.  There is no upper limit placed on the additional proceeds receivable
by the Company as part of the monthly settlements and the amount available in subsequent
months is not affected.  Should the Measured Price be below the Benchmark Price,
the Company will receive less than 100 per cent. of the monthly settlement calculated
on a _pro rata_ basis and the Company will not be entitled to receive the shortfall
at any later date. As such, the final determination of the total amounts to be received
under the Sharing Agreement will only be known after the 24 months have elapsed.

For example, if on a monthly settlement date the calculated Measured Price exceeds
the Benchmark Price by 10 per cent., the settlement on that monthly settlement date
will be 110 per cent. of the amount due from Lanstead on that date.  If on the monthly
settlement date the calculated Measured Price is below the Benchmark Price by 10
per cent., the settlement on the monthly settlement date will be 90 per cent. of
the amount due on that date. Each settlement as so calculated will be in final settlement
of Lanstead’s obligation on that settlement date.

Assuming the Measured Price equals the Benchmark Price on the date of each and every
monthly settlement, nanosynth would receive 24 monthly settlement amounts (23 monthly
amounts of £122,604.17 and the final month of £122,604.09) totalling in aggregate
proceeds of £2,942,500 (before expenses) from the Lanstead Subscription and Sharing
Agreement. Examples of the proceeds from the Sharing Agreement to be received each
month, based upon varying levels of average share price in the month, are shown 
in the Appendix to this announcement.

The Company will pay Lanstead’s legal costs of up to £20,000 incurred in connection
with the Lanstead Subscription and in entering into the Sharing Agreement and, in
addition, has agreed to issue to Lanstead 37,450,000 new Ordinary Shares (“Value
Payment Shares”) in connection with entering into the Sharing Agreement.

**In no event will fluctuations in the Company’s share price result in any increase
in the number of Lanstead Subscription Shares issued by the Company or received 
by Lanstead.**  The Sharing Agreement allows both Lanstead and the Company to benefit
from future share price appreciation.

In total, Lanstead will be issued with 535,000,000 new Ordinary Shares pursuant 
to the Lanstead Subscription which, when issued, will equate (together with the 
37,450,000 Value Payment Shares) to approximately 21.59 per cent. of the Company’s
enlarged issued share capital following Admission.

No shares, warrants or additional fees are owed to Lanstead at any point during 
this agreement other than those disclosed above.

The Directors believe that the Sharing Agreement potentially provides a number of
benefits to the Company and its shareholders including: the certainty of additional
investment, albeit the amount of proceeds to be received under the agreements is
wholly dependent on the Company’s share price each month over the term of the Sharing
Agreement; the opportunity to benefit from positive future share price performance;
and that the amount of shares issued is fixed, together with the cost of their issue.

**Authority to allot shares**

The allotment of the Lanstead Subscription Shares, and the Value Payment Shares 
is being made pursuant to existing authorities to allot shares and other relevant
securities and to disapply pre-emption rights under section 551 of the Companies
Act 2006, which the Directors were given at the Company’s Annual General Meeting
held on 26 July 2022.

**Admission and Total Voting Rights**

Application will be made for the Lanstead Subscription Shares and the Value Payment
Shares to be admitted to trading on the AIM market of the London Stock Exchange (“
Admission”). It is anticipated that Admission to AIM will occur at 8.00 am, on or
around 01 September 2022.

Following Admission the Company will have 2,651,521,986 Ordinary Shares in issue.
The figure of 2,651,521,986 may be used by the Company’s shareholders as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company under the Financial
Conduct Authority’s Disclosure Guidance and Transparency Rules.

**About Lanstead**

Lanstead is a global investment firm that provides funding for ongoing business 
objectives to listed small and mid-cap growth companies. In London, Lanstead focus
on equity investments in companies already listed or quoted on the London Stock 
Exchange or European exchanges and on management teams with a clear growth strategy.

Lanstead’s extensive experience allows it to invest in most industries, focusing
on providing supportive, longer term capital that rewards company growth. Companies
with Lanstead on the shareholder register via an equity placement to Lanstead with
an accompanying sharing agreement can benefit from a unique and flexible approach
to finance growth. This provides the opportunity for companies to benefit from additional
cash beyond the original placing proceeds without having to issue additional shares.

**Appendix – example returns from the Lanstead Sharing Agreement**

In relation to each of the months in the 24 month calculation period:

| _Average 20 Day VWAP_ | 0.55p | 0.73p | 0.92p | 
| _Benchmark Price_ | 0.7333p | 0.7333p | 0.7333p | 
| _20 day VWAP as % of Benchmark Price_ | 75% | 100% | 125% | 
| _Settlement from Lanstead in the month_ | £91,954 | £122,606 | £153,257 | 
| _Proceeds over 24 month period if Average 20 Day VWAP is at this level for the entire period_ | £2,206,908 | £2,942,500 | £3,678,180 |

Share on:
